Price T Rowe Associates Inc. MD Buys 30,625 Shares of Paycor HCM, Inc. (NASDAQ:PYCR)

Price T Rowe Associates Inc. MD lifted its stake in shares of Paycor HCM, Inc. (NASDAQ:PYCR) by 8.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 377,637 shares of the company’s stock after purchasing an additional 30,625 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.21% of Paycor HCM worth $7,013,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the stock. Barclays PLC boosted its holdings in Paycor HCM by 50.8% in the 3rd quarter. Barclays PLC now owns 23,991 shares of the company’s stock valued at $340,000 after purchasing an additional 8,079 shares during the period. Franklin Resources Inc. boosted its stake in Paycor HCM by 2.7% during the third quarter. Franklin Resources Inc. now owns 1,734,109 shares of the company’s stock valued at $23,220,000 after buying an additional 46,127 shares during the period. Principal Financial Group Inc. purchased a new position in Paycor HCM during the third quarter worth about $962,000. Diversified Trust Co bought a new position in Paycor HCM in the 4th quarter worth about $273,000. Finally, Octavia Wealth Advisors LLC raised its holdings in shares of Paycor HCM by 38.5% in the 4th quarter. Octavia Wealth Advisors LLC now owns 14,002 shares of the company’s stock valued at $260,000 after acquiring an additional 3,890 shares in the last quarter. Hedge funds and other institutional investors own 36.76% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on PYCR. Citigroup increased their price objective on Paycor HCM from $21.00 to $22.50 and gave the company a “neutral” rating in a research report on Thursday, January 16th. Stephens reissued an “equal weight” rating and issued a $22.50 target price (up previously from $20.00) on shares of Paycor HCM in a research note on Friday, January 10th. Robert W. Baird reaffirmed a “neutral” rating and issued a $22.50 price target (down from $28.00) on shares of Paycor HCM in a research note on Friday, February 7th. Raymond James lowered Paycor HCM from a “moderate buy” rating to a “hold” rating in a research note on Monday, January 13th. Finally, Citizens Jmp downgraded shares of Paycor HCM from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 9th. One analyst has rated the stock with a sell rating, sixteen have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.53.

Paycor HCM Price Performance

PYCR opened at $22.49 on Friday. The stock has a market cap of $4.09 billion, a PE ratio of -187.40, a PEG ratio of 3.84 and a beta of 0.50. The business has a 50 day moving average of $22.42 and a 200-day moving average of $20.41. Paycor HCM, Inc. has a 52 week low of $10.92 and a 52 week high of $23.49.

Paycor HCM (NASDAQ:PYCR) last released its earnings results on Wednesday, February 5th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.04). Paycor HCM had a positive return on equity of 4.28% and a negative net margin of 3.06%. Equities analysts anticipate that Paycor HCM, Inc. will post 0.3 EPS for the current year.

Paycor HCM Profile

Paycor HCM, Inc, together with its subsidiaries, provides software-as-a-service (SaaS) human capital management (HCM) solutions for small and medium-sized businesses (SMBs) primarily in the United States. It offers cloud-native platform to address the comprehensive people management needs of SMB leaders.